T-Cell Specificity Matters in IBD: Impaired IL10 Production Revealed by OmpC-Tetramers C rohn's disease (CD) is a is a chronic inflammatory disorder of the intestinal mucosa. Uncontrolled cycles of inflammation result in cumulative intestinal damage and there is an urgent need to find better ways to prevent or treat symptoms as early as possible. Effective intervention, however, requires knowledge of the triggers for disease onset and immune cells driving pathology. A key question in the study of CD, and indeed in inflammatory bowel disease (IBD) in general, has been: what are the antigens that drive this inappropriate immunity? In contrast to classic autoimmune diseases in which immune cells react inappropriately to self-antigens, accumulating evidence suggests that in IBD, the inappropriate response is to antigens from the intestinal microbiome. Early evidence from the seminal studies of Targan and Elson have shown that a significant proportion of CD patients have high levels of antibodies to bacterial flagellin proteins from Clostridium cluster XIVa (reviewed in 1). In support of the concept that bacterial antigens drive IBD, there are associations between the frequency and phenotype of bacterial-specific CD4 þ T cells and IBD disease severity. 2-4 However, a limitation of these studies was that specific epitopes were not mapped, meaning that it was not possible to create tetramer reagents, mainstay reagents in the immunology tool box, which allow precise quantification and phenotypic characterization of antigen-specific T cells. Seeking to overcome this limitation, Uchida et al 5 used tetramer-guided mapping to identify T-cell epitopes within the Escherichia coli outer-membrane porin C (OmpC), an antigen previously associated with perforating disease in CD patients. 6 They elected to focus on HLA-DRB1*15:01-restricted epitopes because there was a high frequency of this HLA type in their cohort of individuals with OmpC-specific antibodies. They subsequently identified an HLA-DRB1*15:01-restricted OmpC epitope, OmpC 321-340 , enabling tetramer-based analysis of antigen-specific CD4 þ T cells. Consistent with previous reports 2-4 of bacterial-specific T cells in IBD, Uchida et al 5 found that there was no difference between healthy controls and CD patients in the absolute number of circulating OmpC 321-340-specific CD4 þ T cells. In addition, as previously observed, 2,3 OmpC 321-340-specific CD4 þ T cells had a T-helper 17 cell phenotype, defined as CD161 þ CXCR3 neg. After sorting and clonal expansion, tetramer þ OmpC 321-340-specific cells retained antigen specificity and, strikingly, clones from CD patients secreted significantly less interleukin (IL)10 than those from healthy controls.